Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy

NCT00851565 is registered in ClinicalTrials.gov with Copenhagen University Hospital at Herlev as lead sponsor.

NCT NCT00851565
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00851565 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Combined Measurements of Serum Infliximab and Anti-infliximab Antibodies in the Treatment of Patients With Crohns Disease Failing Infliximab Therapy
Lead sponsor
Copenhagen University Hospital at Herlev
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2009
Completion date
February 28, 2014
Enrollment
120 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease